68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers
NCT06754345 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-05-15
Summary
To evaluate the potential usefulness of 68Ga-NK224 positron emission tomography/computed tomography (PET/CT) for the evaluation of PD-L1 expression in primary and/or metastatic tumors, compared with histopathological results.
Conditions
- Tumor
- PD-L1
Sponsors & Collaborators
-
The First Affiliated Hospital of Xiamen University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-05-30
- Primary Completion
- 2026-11-30
- Completion
- 2026-11-30
Countries
- China
Study Locations
More Related Trials
-
PD-L1 Expression in Lung Cancer
NCT04992715 ·Status: UNKNOWN ·Phase: PHASE2
-
Consistency Analysis of PD-L1s in Advanced NSCLC Tissues and in Plasma Exosomes Before and After Radiotherapy
NCT02869685 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Radiation Therapy With Wide Detector 4DCT Scanning for Primary or Metastatic Lung Cancer
NCT06233396 ·Status: COMPLETED
-
Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction
NCT03053804 ·Status: UNKNOWN ·Phase: NA
-
Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer
NCT05617742 ·Status: COMPLETED ·Phase: NA
-
Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer
NCT06194630 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer
NCT06895941 ·Status: WITHDRAWN
-
Multimodalitic Imaging in the N-stage of Lung Cancer
NCT05840094 ·Status: UNKNOWN ·Phase: NA
-
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
NCT02803619 ·Status: UNKNOWN
-
Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLC
NCT04586465 ·Status: UNKNOWN ·Phase: PHASE2
-
PD-L1 Expression in Advanced Osteosarcoma
NCT03582527 ·Status: UNKNOWN
-
A Clinical Study of the Cryoablation Technique for Peripheral Lung Malignancies
NCT06832969 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC)
NCT01065415 ·Status: COMPLETED
-
Study on the Diagnosis of Ground-glass Lung Cancer by Microwave Ablation Combined With Puncture Biopsy
NCT06776588 ·Status: RECRUITING ·Phase: NA
-
Consistency of PD-L1 Detecting Method Between E1L3N and 22C3 Monoclonal Antibodies in NSCLC Patients
NCT05129462 ·Status: COMPLETED
-
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
NCT06869239 ·Status: RECRUITING
-
Independent Predictors Analysis and Model Construction of Cavitary Central Lung Cancer
NCT05278754 ·Status: UNKNOWN
-
Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLC
NCT04886401 ·Status: RECRUITING
-
Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiotherapy
NCT04654234 ·Status: COMPLETED
-
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan
NCT06358222 ·Status: RECRUITING
-
Efficacy and Safety of Cryoablation with Robotic Bronchoscopy System in Patients with Lung Cancer
NCT06832956 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Radiomics for prEdiction of lunG cAncer biologY
NCT05819905 ·Status: UNKNOWN
-
Transthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung Cancer
NCT06572540 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Clinical Significance and Feasibility of CT Guided Biopsy of Double Site Lesions:A Preliminary Lung Centered Study
NCT04960631 ·Status: COMPLETED
-
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer
NCT05425134 ·Status: UNKNOWN